118 related articles for article (PubMed ID: 8093578)
1. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
Yoshida M; Ogawa M; Suzuki K; Nagatsu T
Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
[TBL] [Abstract][Full Text] [Related]
2. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes.
Yoshida M; Niwa T; Nagatsu T
Neurosci Lett; 1990 Oct; 119(1):109-13. PubMed ID: 1982957
[TBL] [Abstract][Full Text] [Related]
3. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
Nagatsu T; Yoshida M
Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
[TBL] [Abstract][Full Text] [Related]
4. [Tetrahydroisoquinoline and parkinsonism].
Yoshida M
Rinsho Shinkeigaku; 1989 Dec; 29(12):1501-3. PubMed ID: 2630145
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
[TBL] [Abstract][Full Text] [Related]
6. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
[No Abstract] [Full Text] [Related]
7. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
[TBL] [Abstract][Full Text] [Related]
9. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Rioux L; Frohna PA; Joyce JN; Schneider JS
Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Senda M; Sano T
J Neurochem; 2001 Nov; 79(4):868-76. PubMed ID: 11723179
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Naoi M; Maruyama W; Kasamatsu T; Dostert P
J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
[TBL] [Abstract][Full Text] [Related]
12. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1,2,3,4-tetrahydroisoquinoline derivatives on dopaminergic spontaneous discharge in substantia nigra neurons in rats.
Chiba H; Sato H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
Pharmacology; 2015; 95(1-2):87-94. PubMed ID: 25633935
[TBL] [Abstract][Full Text] [Related]
14. Effect of tetrahydroisoquinoline (TIQ), one of endogenous substances inducing parkinsonism, on isolated rat vas deferens.
Koike K; Takayanagi I; Wani S; Yanagita T; Ohta S; Hirobe M
Gen Pharmacol; 1989; 20(2):259-60. PubMed ID: 2714622
[TBL] [Abstract][Full Text] [Related]
15. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry.
Niwa T; Takeda N; Tatematsu A; Matsuura S; Yoshida M; Nagatsu T
J Chromatogr; 1988 Oct; 452():85-91. PubMed ID: 3149649
[TBL] [Abstract][Full Text] [Related]
16. Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system.
Koshimura I; Imai H; Hidano T; Endo K; Mochizuki H; Kondo T; Mizuno Y
Brain Res; 1997 Oct; 773(1-2):108-16. PubMed ID: 9409711
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice.
Perry TL; Jones K; Hansen S
Neurosci Lett; 1988 Feb; 85(1):101-4. PubMed ID: 3362404
[TBL] [Abstract][Full Text] [Related]
18. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?
Ossowska K; Wardas J; Smiałowska M; Kuter K; Lenda T; Wierońska JM; Zieba B; Nowak P; Dabrowska J; Bortel A; Kwieciński A; Wolfarth S
Eur J Neurosci; 2005 Sep; 22(6):1294-304. PubMed ID: 16190885
[TBL] [Abstract][Full Text] [Related]
19. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
